BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $755,977 | +0.7% | 16,593 | -10.3% | 0.00% | 0.0% |
| Q1 2023 | $750,684 | -24.2% | 18,508 | -4.7% | 0.00% | -25.0% |
| Q4 2022 | $990,194 | -9.3% | 19,427 | -4.2% | 0.00% | -20.0% |
| Q3 2022 | $1,092,000 | -17.6% | 20,284 | -1.6% | 0.01% | 0.0% |
| Q2 2022 | $1,325,000 | -19.1% | 20,622 | -2.3% | 0.01% | -16.7% |
| Q1 2022 | $1,637,000 | -11.2% | 21,116 | -1.6% | 0.01% | 0.0% |
| Q4 2021 | $1,843,000 | -9.9% | 21,469 | -15.6% | 0.01% | -14.3% |
| Q3 2021 | $2,046,000 | -17.5% | 25,434 | -17.4% | 0.01% | -22.2% |
| Q2 2021 | $2,479,000 | +22.7% | 30,799 | +28.6% | 0.01% | +28.6% |
| Q1 2021 | $2,020,000 | -5.0% | 23,951 | -9.6% | 0.01% | -12.5% |
| Q4 2020 | $2,127,000 | +7.9% | 26,502 | +8.1% | 0.01% | -11.1% |
| Q3 2020 | $1,971,000 | -8.6% | 24,509 | -2.1% | 0.01% | -10.0% |
| Q2 2020 | $2,156,000 | +5.3% | 25,037 | -0.7% | 0.01% | -16.7% |
| Q1 2020 | $2,047,000 | +1.2% | 25,209 | +4.2% | 0.01% | +20.0% |
| Q4 2019 | $2,022,000 | +13.9% | 24,186 | +19.2% | 0.01% | +11.1% |
| Q3 2019 | $1,775,000 | +16.3% | 20,292 | +8.1% | 0.01% | -25.0% |
| Q1 2019 | $1,526,000 | +46.9% | 18,766 | +18.9% | 0.01% | +300.0% |
| Q4 2018 | $1,039,000 | -20.4% | 15,786 | -6.8% | 0.00% | -57.1% |
| Q3 2018 | $1,305,000 | +6.2% | 16,930 | +1.7% | 0.01% | 0.0% |
| Q2 2018 | $1,229,000 | +16.1% | 16,643 | +2.2% | 0.01% | +16.7% |
| Q1 2018 | $1,059,000 | -4.8% | 16,288 | -5.3% | 0.01% | 0.0% |
| Q4 2017 | $1,112,000 | +0.5% | 17,197 | -2.5% | 0.01% | -14.3% |
| Q3 2017 | $1,106,000 | +1.8% | 17,631 | -1.7% | 0.01% | 0.0% |
| Q2 2017 | $1,086,000 | – | 17,940 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |